UMC Utrecht Cancer Center
About UMC Utrecht Cancer Center
The University Medical Center Utrecht is the main hospital of the city of Utrecht, Netherlands. It is affiliated with the Utrecht University. Since the foundation of the university in 1636 an academic hospital has existed in various forms.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Cellestia Biotech AG
1
Crescendo Biologics Ltd.
1
Genmab
1
Novartis Pharmaceuticals
1
Polyneuron Pharmaceuticals AG
1
Telix International Pty Ltd
1
Clinical Trials at UMC Utrecht Cancer Center
During the past decade, UMC Utrecht Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors
2016-11-23
2021-11-12
Completed
306
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
2017-12-05
2022-11-11
Terminated
79
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
2019-05-07
2026-02-14
Active, not recruiting
331
First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
2020-11-17
2021-09-23
Terminated
1
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.
2021-06-08
2023-09-25
Recruiting
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UMC Utrecht Cancer Center" #1 sponsor was "Cellestia Biotech AG" with 1 trials, followed by "Crescendo Biologics Ltd." with 1 trials
sponsored, "Genmab" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Polyneuron Pharmaceuticals AG"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at UMC Utrecht Cancer Center
According to Clinical.Site data, the most researched conditions in "UMC Utrecht Cancer Center" are
"Adenoid Cystic Carcinoma" (1 trials), "Advanced and/or Metastatic Solid Tumours" (1 trials), "Anti-MAG Neuropathy" (1 trials), "Breast Cancer" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "UMC Utrecht Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at UMC Utrecht Cancer Center
Most popular intervention types in "UMC Utrecht Cancer Center" are "Drug" (4 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "4-L-[131I]iodo-phenylalanine (131I-IPA)" (1 trials), "CB-103" (1 trials), "CB307" (1 trials), "Enapotamab vedotin (HuMax-AXL-ADC)" (1 trials) and "PPSGG" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UMC Utrecht Cancer Center
The vast majority of trials in "UMC Utrecht Cancer Center" are
6 trials for "All" genders.
Clinical Trials Status at UMC Utrecht Cancer Center
Currently, there are NaN active trials in "UMC Utrecht Cancer Center".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in UMC Utrecht Cancer Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in UMC Utrecht Cancer Center, 5 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".